123 related articles for article (PubMed ID: 9794566)
41. Reduced plasmalogen concentration as a surrogate marker of oxidative stress in elderly septic patients.
Brosche T; Bertsch T; Sieber CC; Hoffmann U
Arch Gerontol Geriatr; 2013; 57(1):66-9. PubMed ID: 23522521
[TBL] [Abstract][Full Text] [Related]
42. Hemodialysis induces p66(shc) gene expression in nondiabetic humans: correlations with oxidative stress and systemic inflammation.
Zanetti M; Barazzoni R; Gortan Cappellari G; Burekovic I; Bosutti A; Stocca A; Bianco F; Ianche M; Panzetta G; Guarnieri G
J Ren Nutr; 2011 Sep; 21(5):401-9. PubMed ID: 21439852
[TBL] [Abstract][Full Text] [Related]
43. [Oxidative stress in end stage renal disease: evidence and association with cardiovascular events in Tunisian patients].
Fellah H; Feki M; Souissi M; Ghorbel H; Ben Abdallah T; Massy Z; Hedhili A; Ben Maiz H; Lacour B; Kaabachi N; Mebazaa A
Tunis Med; 2006 Nov; 84(11):724-9. PubMed ID: 17294900
[TBL] [Abstract][Full Text] [Related]
44. Decreased serum aminotransferase activity in patients with chronic renal failure: impact on the detection of viral hepatitis.
Fabrizi F; Lunghi G; Finazzi S; Colucci P; Pagano A; Ponticelli C; Locatelli F
Am J Kidney Dis; 2001 Nov; 38(5):1009-15. PubMed ID: 11684554
[TBL] [Abstract][Full Text] [Related]
45. [Nutritional status evaluation in maintenance hemodialysis patients].
Segall L; Covic A; Mardare N; Ungureanu S; Marian S; Busuioc M; Nistor I; Enache R; Veisa G; Covic M
Rev Med Chir Soc Med Nat Iasi; 2008; 112(2):343-50. PubMed ID: 19295002
[TBL] [Abstract][Full Text] [Related]
46. Impaired renal function and duration of dialysis therapy are associated with oxidative stress and proatherogenic cytokine levels in patients with end-stage renal disease.
Pawlak K; Pawlak D; Mysliwiec M
Clin Biochem; 2007 Jan; 40(1-2):81-5. PubMed ID: 17046733
[TBL] [Abstract][Full Text] [Related]
47. Hyperhomocysteinemia, nutritional status, and cardiovascular disease in hemodialysis patients.
Suliman ME; Qureshi AR; Bárány P; Stenvinkel P; Filho JC; Anderstam B; Heimbürger O; Lindholm B; Bergström J
Kidney Int; 2000 Apr; 57(4):1727-35. PubMed ID: 10760109
[TBL] [Abstract][Full Text] [Related]
48. Total antioxidant capacity (TAC): is it an effective method to evaluate the oxidative stress in uraemia?
Bergesio F; Monzani G; Ciuti R; Pinzani P; Fiaschi N; Priami F; Cirami C; Ciccarelli C; Salvadori M
J Biolumin Chemilumin; 1998; 13(5):315-9. PubMed ID: 9839198
[TBL] [Abstract][Full Text] [Related]
49. Assessing the prevalence of malnutrition in chronic kidney disease patients in jordan.
Tayyem RF; Mrayyan MT
J Ren Nutr; 2008 Mar; 18(2):202-9. PubMed ID: 18267213
[TBL] [Abstract][Full Text] [Related]
50. The effect of i.v. iron alone or in combination with low-dose erythropoietin in the rapid correction of anemia of chronic renal failure in the predialysis period.
Silverberg DS; Blum M; Agbaria Z; Deutsch V; Irony M; Schwartz D; Baruch R; Yachnin T; Steinbruch S; Iaina A
Clin Nephrol; 2001 Mar; 55(3):212-9. PubMed ID: 11316241
[TBL] [Abstract][Full Text] [Related]
51. Homocysteine and carotid atherosclerosis in chronic renal failure--the confounding effect of renal function.
Leskinen Y; Lehtimäki T; Loimaala A; Huhtala H; Salenius JP; Oja SS; Saha H
Atherosclerosis; 2004 Aug; 175(2):315-23. PubMed ID: 15262188
[TBL] [Abstract][Full Text] [Related]
52. Validity of subjective global assessment as a nutritional marker in end-stage renal disease.
Cooper BA; Bartlett LH; Aslani A; Allen BJ; Ibels LS; Pollock CA
Am J Kidney Dis; 2002 Jul; 40(1):126-32. PubMed ID: 12087570
[TBL] [Abstract][Full Text] [Related]
53. Malonyldialdehyde content of cell membranes is the most important marker of oxidative stress in haemodialysis patients.
Taccone-Gallucci M; Lubrano R; Meloni C; Morosetti M; Adolfo CM; Casciani CU
Nephrol Dial Transplant; 1998 Oct; 13(10):2711-2. PubMed ID: 9794603
[No Abstract] [Full Text] [Related]
54. Association of Depression With Selenium Deficiency and Nutritional Markers in the Patients With End-Stage Renal Disease on Hemodialysis.
Ekramzadeh M; Mazloom Z; Sagheb M
J Ren Nutr; 2015 Jul; 25(4):381-7. PubMed ID: 25680525
[TBL] [Abstract][Full Text] [Related]
55. Red blood cell membrane lipid peroxidation and resistance to erythropoietin therapy in hemodialysis patients.
Gallucci MT; Lubrano R; Meloni C; Morosetti M; Manca di Villahermosa S; Scoppi P; Palombo G; Castello MA; Casciani CU
Clin Nephrol; 1999 Oct; 52(4):239-45. PubMed ID: 10543326
[TBL] [Abstract][Full Text] [Related]
56. [Increased levels of advanced oxidation protein products are associated with atherosclerosis in chronic kidney disease].
Yang XB; Hou FF; Wu Q; Zhou H; Liu ZR; Yang Y; Zhang X
Zhonghua Nei Ke Za Zhi; 2005 May; 44(5):342-6. PubMed ID: 16009002
[TBL] [Abstract][Full Text] [Related]
57. Skeletal status in children and adolescents with chronic renal failure before onset of dialysis or on dialysis.
Pluskiewicz W; Adamczyk P; Drozdzowska B; Szprynger K; Szczepańska M; Halaba Z; Karasek D
Osteoporos Int; 2003 Jun; 14(4):283-8. PubMed ID: 12730774
[TBL] [Abstract][Full Text] [Related]
58. A cohort study of subjective global assessment and mortality in Taiwanese hemodialysis patients.
Yang FL; Lee RP; Wang CH; Fang TC; Hsu BG
Ren Fail; 2007; 29(8):997-1001. PubMed ID: 18067047
[TBL] [Abstract][Full Text] [Related]
59. Skeletal muscle function in chronic renal failure: an index of nutritional status.
Berkelhammer CH; Leiter LA; Jeejeebhoy KN; Detsky AS; Oreopoulos DG; Uldall PR; Baker JP
Am J Clin Nutr; 1985 Nov; 42(5):845-54. PubMed ID: 4061346
[TBL] [Abstract][Full Text] [Related]
60. Serum levels of soluble adhesion molecules in chronic renal failure and dialysis patients.
Bonomini M; Reale M; Santarelli P; Stuard S; Settefrati N; Albertazzi A
Nephron; 1998 Aug; 79(4):399-407. PubMed ID: 9689154
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
